|Original language||English (US)|
|Number of pages||14|
|State||Published - Feb 2022|
Bibliographical noteFunding Information:
We would like to thank Drs. Rozalyn Anderson, Paul Robbins, and Laura Nidernhofer for their role in the establishment of the MAC and their contributions to this meeting as well as this report. In addition, we would like to thank the American Aging Association for organizing the meeting at which these talks were presented, and a special thanks to all sponsors of the 49th Annual AGE Metabolism of Aging Conference, including Gentech; School of Medicine and Public Health at University of Wisconsin-Madison; Geriatrics and Gerontology at University of Wisconsin-Madison; American Aging Association; American Federation for Aging Research; The Glenn Foundation for Medical Research; Morgridge Institute for Research; Orentreich Foundation for the Advancement of Science, Inc.; National Institutes of Health: National Institute on Aging; Healthy Aging & Longevity Research Institute; and Calico.
C.L.G. is supported by a Glenn/AFAR Foundation for Medical Research Postdoctoral Fellowship in Aging Research. M.J.Y. is supported by the Irene Diamond Fund/American Federation for Aging Research Postdoctoral Transition Award and in part by funds from the NIH/NIA (AG063543, AG059676, and AG056278 to Drs. Laura Niedernhofer and Paul Robbins). H.H.P. is supported by a NIA F31 predoctoral fellowship (NIA F31 AG066311). M.E.M. is supported by a Research Supplement to Promote Diversity in Health-Related Research (R01AG062328-03S1). C-Y.Y. is supported by the T32 Biology of Aging Program (T32 AG000213). D.W.L. and the Lamming laboratory are supported in part by research grants and funds from the National Institutes of Health (AG056771, AG062328 and DK125859) the University of Wisconsin-Madison School of Medicine and Public Health and Department of Medicine, and the U.S. Department of Veterans Affairs (I01-BX004031). T.W.R. is supported in part by funds from the NIH/NIA (AG070686 to TWR and AG057408 to Dr. Rozalyn Anderson) and the U.S. Department of Veterans Affiars (I01-BX003846 to Dr. Rozalyn Anderson). J.P.C. has received support from the T32 Biology of Aging Program (T32 AG000213). H.B., A.K., M.B., and the Bai laboratory is supported by NIH/NIA R01AG058741. J.M.D. is supported by GM059785, GM65386 and DK125859. C.S.M. has received support for this work by a NIH T32 T32GM008688, D.L.M. has received support for this work by an AFAR Young Investigator Award, a Sloan Foundation fellowship, and a DP2 NIH New Innovator Award. Y.P.R.J has received funding from NIGMS/NIA (AG056881). JS has received support from the NIH BIRCWH K12HD101368, start up funds from the Department of Biochemistry, and the NIH DRC P30DK020579. K.L. has received support from the T32 AG029796. V.M. has received support from NIH/NIA R01 AG063543, U19 AG056278, P01 AG062413, and Aligning Science across Parkinson’s ASAP-000592.Y.Z. and R.Y. are supported by William E. McElroy Charitable Foundation, NIA R21AG062985, ADA 1–19-IBS-126 and Research seed grant of Southern Illinois University School of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work does not represent the views of the Department of Veterans Affairs or the United States Government.